New inhibitors of matrix metalloproteinases 9 (MMP-9): Lignans from Selaginella moellendorffii

被引:15
|
作者
Zhu, Yuan [1 ]
Huang, Ri-Zhen [2 ,3 ]
Wang, Chun-Gu [1 ]
Ouyang, Xi-Lin [1 ]
Jing, Xiao-Teng [1 ]
Liang, Dong [1 ]
Wang, Heng-Shan [1 ]
机构
[1] Guangxi Normal Univ, Sch Chem & Pharmaceut Sci, State Key Lab Chem & Mol Engn Med Resources, 15 Yucai Rd, Guilin 541004, Guangxi, Peoples R China
[2] Southeast Univ, Pharmaceut Res Ctr, Nanjing, Jiangsu, Peoples R China
[3] Southeast Univ, Sch Chem & Chem Engn, Nanjing, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Lignans; Selaginella moellendorffii; Matrix metalloproteinase; Migration; Anticancer activity; CANCER PROGRESSION; NEOLIGNANS; INVASION; HIERON; CELLS; METASTASIS; MIGRATION; INSIGHTS;
D O I
10.1016/j.fitote.2018.09.008
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Matrix metalloproteinase 9 (MMP-9) is one of the structurally related zinc-dependent endopeptidases families and provides a new target for cancer therapy owing to its pivotal role in metastatic tumors. In this paper, fourteen lignans, including three novel lignans, named selamoellenin B-D (1-3), and eleven known lignan derivatives (4-14) were isolated from the plant of Selaginella moellendorffii. Among them, compound 3 is optically active, which was enantiomerically seperated to afford a pair of enantiomers, ( - )-3 and ( + )-3. Their structures were elucidated by extensive spectroscopic analyses. Their cytotoxic activities were evaluated against four human cancer cell lines. Among them, five compounds (4, 5, 6, 11 and 13) exhibited great potent cytotoxicity and their structure-activity relationships were also discussed. All compounds except for 3 lignan analogues with low cytotoxicity were selected for further in vitro enzyme inhibition, surface plasmon resonance (SPR), and molecular docking assays based on the MMPs target. The results shown that, compound 11 have the best inhibitory effect and can be considered as a potential drug candidate targeting at MMP-9 for cancer therapy.
引用
收藏
页码:281 / 289
页数:9
相关论文
共 50 条
  • [41] Specific matrix metalloproteinase 9 (MMP-9) haplotype affect the circulating MMP-9 levels in women with migraine
    Martins-Oliveira, Alisson
    Goncalves, Flavia M.
    Speciali, Jose G.
    Fontana, Vanessa
    Izidoro-Toledo, Tatiane C.
    Belo, Vanessa A.
    Dach, Fabiola
    Tanus-Santos, Jose E.
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 252 (1-2) : 89 - 94
  • [42] Elevated circulating levels of matrix metalloproteinases MMP-2 and MMP-9 in pseudoxanthoma elasticum patients
    Diekmann, Ulf
    Zarbock, Ralf
    Hendig, Doris
    Szliska, Christiane
    Kleesiek, Knut
    Goetting, Christian
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2009, 87 (10): : 965 - 970
  • [43] Biphenyl substituted lysine derivatives as recognition elements for the matrix metalloproteinases MMP-2 and MMP-9
    Kirchhain, Arno
    Zubriene, Asta
    Kairys, Visvaldas
    Vivaldi, Federico
    Bonini, Andrea
    Biagini, Denise
    Santalucia, Delio
    Matulis, Daumantas
    Di Francesco, Fabio
    BIOORGANIC CHEMISTRY, 2021, 115
  • [44] Elevated circulating levels of matrix metalloproteinases MMP-2 and MMP-9 in pseudoxanthoma elasticum patients
    Ulf Diekmann
    Ralf Zarbock
    Doris Hendig
    Christiane Szliska
    Knut Kleesiek
    Christian Götting
    Journal of Molecular Medicine, 2009, 87 : 965 - 970
  • [45] Matrix metalloproteinases MMP-2 i MMP-9 in the serum of patients with type 2 diabetes
    Prystupa, Andrzej
    Kancik, Emilia
    Dyczko, Monika
    Dzida, Grzegorz
    Wojtowicz, Tomasz
    Kurzepa, Jacek
    Grabarska, Aneta
    Torun-Jurkowska, Anna
    Stepulak, Andrzej
    Mosiewicz, Jerzy
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2011, 13 (02): : 229 - 232
  • [46] Expression and role of matrix metalloproteinases MMP-2 and MMP-9 in human spinal column tumors
    Ziya L Gokaslan
    Shravan K Chintala
    Julie E York
    Venkaiah Boyapati
    Sushma Jasti
    Raymond Sawaya
    Gregory Fuller
    David M Wildrick
    Garth L Nicolson
    Jasti S Rao
    Clinical & Experimental Metastasis, 1998, 16 : 721 - 728
  • [47] Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer
    Przybylowska, K
    Kluczna, A
    Zadrozny, M
    Krawczyk, T
    Kulig, A
    Rykala, J
    Kolacinska, A
    Morawiec, Z
    Drzewoski, J
    Blasiak, J
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 95 (01) : 65 - 72
  • [48] Plasma matrix metalloproteinases (MMP-2 and MMP-9) as prognostic biomarkers in coronary heart disease
    Marynenko, Tetiana
    Halenova, Tetiana
    Raksha, Nataliia
    Vovk, Tetiana
    Tyravska, Yuliya
    Savchuk, Olexii
    Falalyeyeva, Tetyana
    Fagoonee, Sharmila
    Abenavoli, Ludovico
    Ostapchenko, Liudmyla
    MINERVA BIOTECHNOLOGY AND BIOMOLECULAR RESEARCH, 2022, 34 (03): : 137 - 142
  • [49] Expression of metalloproteinases MMP-2 and MMP-9 in antrochoanal polyps
    Topal, Ozgul
    Erbek, Selim S.
    Kiyici, Halil
    Cakmak, Ozcan
    AMERICAN JOURNAL OF RHINOLOGY, 2008, 22 (04): : 339 - 342
  • [50] Matrix metaloproteinase-9 (MMP-9) modulates mucin: Implication for the role of MMP-9 in the pathogenesis of colitis
    Garg, P
    Ravi, A
    Kumar, MV
    Gewirtz, AT
    Merlin, D
    Sitaraman, SV
    FASEB JOURNAL, 2006, 20 (05): : A1263 - A1263